ReviewMediterranean journal of hematology and infectious diseases2014

Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML).

Ibrahim C HaznedarogluPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.